General Pharmaceuticals Market Research Reports & Industry Analysis


General Pharmaceuticals Industry Research & Market Reports

  • Cannabis Beverages

    ... CAGR of 16.3% over the analysis period 2024-2030. Non-Alcoholic Beverage, one of the segments analyzed in the report, is expected to record a 16.8% CAGR and reach US$2.1 Billion by the end of the analysis ... Read More

  • Calcium Gluconate

    ... CAGR of 6.1% over the analysis period 2024-2030. Calcium Gluconate Powder, one of the segments analyzed in the report, is expected to record a 6.7% CAGR and reach US$64.7 Million by the end of the ... Read More

  • Glutamic Acid

    ... CAGR of 7.9% over the analysis period 2024-2030. Food & Beverage Application, one of the segments analyzed in the report, is expected to record a 8.0% CAGR and reach US$14.6 Billion by the end of ... Read More

  • Betaine

    ... 4.6% over the analysis period 2024-2030. Synthetic Betaine, one of the segments analyzed in the report, is expected to record a 4.1% CAGR and reach US$4.0 Billion by the end of the analysis period. Growth ... Read More

  • Active Pharmaceutical Ingredients (API)

    ... 2030, growing at a CAGR of 6.3% over the analysis period 2024-2030. Innovative APIs, one of the segments analyzed in the report, is expected to record a 6.0% CAGR and reach US$240.8 Billion by the ... Read More

  • Healthcare Distribution

    ... CAGR of 13.5% over the analysis period 2024-2030. Pharmaceutical Distribution, one of the segments analyzed in the report, is expected to record a 13.3% CAGR and reach US$2.3 Trillion by the end of the analysis ... Read More

  • Downstream Processing

    ... CAGR of 15.6% over the analysis period 2024-2030. Purification Technique, one of the segments analyzed in the report, is expected to record a 16.3% CAGR and reach US$60.6 Billion by the end of the analysis ... Read More

  • Empty Capsules

    ... CAGR of 5.5% over the analysis period 2024-2030. Gelatin Capsules, one of the segments analyzed in the report, is expected to record a 5.2% CAGR and reach US$3.5 Billion by the end of the analysis ... Read More

  • Excipients

    ... 4.6% over the analysis period 2024-2030. Polymers, one of the segments analyzed in the report, is expected to record a 4.5% CAGR and reach US$4.4 Billion by the end of the analysis period. Growth in ... Read More

  • Curcumin

    ... 8.7% over the analysis period 2024-2030. Conventional Curcumin, one of the segments analyzed in the report, is expected to record a 7.3% CAGR and reach US$139.3 Million by the end of the analysis period. Growth ... Read More

  • Binder Excipients

    ... CAGR of 5.3% over the analysis period 2024-2030. Cellulosics, one of the segments analyzed in the report, is expected to record a 5.7% CAGR and reach US$1.0 Billion by the end of the analysis period. ... Read More

  • Cannabis Edibles

    ... CAGR of 22.0% over the analysis period 2024-2030. Solid Cannabis Edibles, one of the segments analyzed in the report, is expected to record a 22.2% CAGR and reach US$38.2 Billion by the end of the ... Read More

  • Medical Membranes

    ... CAGR of 7.7% over the analysis period 2024-2030. Ultrafiltration Technology, one of the segments analyzed in the report, is expected to record a 7.9% CAGR and reach US$2.0 Billion by the end of the analysis ... Read More

  • High Potency APIs (HPAPIs)

    ... 2030, growing at a CAGR of 8.5% over the analysis period 2024-2030. Innovative HPAPIs, one of the segments analyzed in the report, is expected to record a 8.2% CAGR and reach US$31.4 Billion by the ... Read More

  • Glucose, Dextrose, and Maltodextrin

    ... 2030, growing at a CAGR of 5.8% over the analysis period 2024-2030. Glucose, one of the segments analyzed in the report, is expected to record a 5.9% CAGR and reach US$32.3 Billion by the end ... Read More

  • Cannabis Testing

    ... CAGR of 13.1% over the analysis period 2024-2030. Cannabis Testing Services, one of the segments analyzed in the report, is expected to record a 14.9% CAGR and reach US$1.7 Billion by the end of the ... Read More

  • Aseptic Sampling

    ... CAGR of 10.1% over the analysis period 2024-2030. Manual Aseptic Sampling, one of the segments analyzed in the report, is expected to record a 11.0% CAGR and reach US$357.4 Million by the end of the ... Read More

  • Aseptic Processing

    ... CAGR of 3.5% over the analysis period 2024-2030. Vials & Ampoules Packaging, one of the segments analyzed in the report, is expected to record a 4.0% CAGR and reach US$51.3 Billion by the end of ... Read More

  • Drugs and Medicaments - International Trade in Q4-2024: Top Markets' Performance by Major Competitors

    ... Drugs and Medicaments recorded a year-over-year increase of +11.2% in $. As regards major competitors of Drugs and Medicaments, in year 2024 Ireland and Italy showed the best results in USD values compared to the ... Read More

  • International Directory of Medical Cannabis Companies 2025

    International Directory of Medical Cannabis Companies 2025 The most comprehensive and accurate Directory of companies and executives in the medical cannabis industry Internationally. Extensive profiles of companies and each company's senior officials. Read More

  • European Pharma Handbook 2025

    European Pharma Handbook 2025 A data-rich report that gives you insight into the structures,trends, and regulations driving the European pharmaceutical market. Extensive profiles of companies and each company's senior officials. Read More

  • Global Pharma Handbook 2025

    Global Pharma Handbook 2025 A data-rich report that gives you insight into the structures,trends, and regulations driving the World's largest pharmaceutical markets. Extensive profiles of companies and each company's senior officials. Read More

  • Active Pharmaceutical Ingredients Directory 2025

    ... Directory 2025 The Active Pharmaceutical Ingredients Directory contains corporate information, senior executives, contact details email addresses of those working in every segment of the API marketplace, & includes important information on manufacturers, distributors & agencies. Read More

  • Canada CBD-Infused Beverages Market - 2024-2031

    ... period 2024-2031. Consumers of the country are increasingly seeking wellness-oriented, non-intoxicating alternatives to traditional beverages, and CBD-infused drinks fit this demand. These products are marketed for their potential health benefits, such as stress relief, anxiety ... Read More

  • Global Drug Abuse Testing Market - 2025 - 2033

    ... of 5.3% during the forecast period 2025-2033. Drug abuse testing is a crucial process for detecting prescription drugs in a person's system, ensuring safety, compliance, and medical evaluation. It is used in workplace screening, forensic ... Read More

< prev 1 2 3 4 5 6 7 8 9 10

Research Assistance

Live help

Join Alert Me Now!

Sign Up

Find out more on our blog
Cookie Settings